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ABSTRACT 
 
 Stem cells are undifferentiated cells with the ability to renew and divide 
indefinitely to generate specialized cells, thus they show medical potential for treating 
and curing currently untreatable diseases.  This project investigated the different types of 
stem cells, how they have been used, and the effects of this new technology on society 
via ethical and legal issues.   
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EXECUTIVE SUMMARY 
 
 Stem cells are undifferentiated cells with the capacity to grow indefinitely and to 
differentiate into tissues.  Because of this regenerative capacity, stem cells have the 
potential to regenerate tissues, and is the basis for the new field of regenerative medicine.  
One common misconception is that all stem cells are alike, so one purpose of this IQP 
was to document in chapter-1 the various kinds of stem cells, including embryonic stem 
(ES) cells and various kinds of adult stem cells.  Another source of misinformation is 
what has or has not been achieved with stem cells so far.  Some observes argue that no 
human lives have yet to be saved with stem cells, yet they forget about the thousands of 
lives already saved with bone marrow transplants using hematopoietic stem cells.   So the 
purpose of chapter-2 of this IQP was to document what has been done with stem cells in 
both humans and animals.  The use of some stem cells can destroy human embryos, so 
chapter-3 focused on stem cells ethics, and the stances of the major world’s religions.  
Finally, chapter-4 focused on U.S. and state laws governing stem cell use, comparing 
them to other countries. 
 Chapter-1 serves as an introduction to the different types and sources of stem 
cells, and provides some basic definitions. Stem cells share three common properties.  All 
stem cells must be: 1) capable of renewing and dividing for extended periods of time, 2) 
unspecialized, and 3) able to give rise to specialized cells (Stem Cell Basics, 2005).  A 
stem cell is often described in terms of its potency, or the number of different kinds of 
specialized cells that it has the ability to produce. Totipotentcy, meaning it has the ability 
to give rise to any embryonic or adult tissue cell, is a characteristic of a fertilized egg. 
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Embryonic stem (ES) cells are considered to be pluripotent, with the ability to make 
almost all kinds of cells in the body.  Multipotent stem cells are capable of making 
various kinds of cells of one tissue, and unipotent stem cells are capable of forming only 
the same type of cell from a specific tissue.  
 Chapter-2 explores some of the possible applications for stem cells.  For example 
hematopoietic stem cells (HSC) have been used for many years in Leukemia patients to 
reconstitute the cellular components of blood to send the Leukemia into an ultimate 
remission.  Most of what we know about stem cells comes from animal studies, 
especially mice, and we document some key experiments in chapter-2.  With respect to 
humans, ES cell experiments are only now in clinical trials, so researchers have yet to tap 
into the vast potential of using stem cells to fight many diseases. Diabetes could be 
fought with ES cell therapy where the cells could provide the necessary amount of insulin 
for survival. Stem cells could be transplanted to fight diseases of the human nervous 
system such as Parkinson’s disease. Use of stem cells could also one day help repair the 
tissues of the heart which is so vital to our daily survival. These are but a few of the many 
potential benefits that the promise of stem cell research can bring.  
 Chapter-3 addresses the ethical concerns that have made this such a heated topic. 
The traditional Hindu belief is that life begins at conception, which is the point when a 
person is reborn from their previous life, or reincarnated.  However, Swami Tyagananda, 
a Hindu chaplain at the MIT Religious Activities Center, argues that ES cell research and 
therapy may be justifiable as it is considered an “extraordinary, unavoidable 
circumstance,” and an act done “for the greater good”( Reichhardt, 2004).  Traditional 
Muslim belief supports ES cell research since they argue life begins forty days after 
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fertilization, well after blastocyst formation from which ES cells are obtained.  Those of 
the Jewish faith believe that the human embryo is not given human status until the 40th 
day of gestation as well, permitting the use of ES cells provided that the fetus was 
aborted in accordance with Jewish law. Some Christians approve of ES cell research 
under certain conditions, while others believe that it is unethical under any circumstances. 
Catholic officials are strictly opposed to the destruction of human embryos under any 
conditions, ES cell research is “immoral, illegal, and unnecessary,” as said by the U.S. 
Roman Catholic Bishops (Religious Views…2001).  All four of the world’s main 
religions support the use of adult stem cells to save lives, since no embryos are destroyed 
in the process. 
 Chapter-4 summarizes current stem cell legalities, and provides a historical 
perspective leading up to current U.S. policies.  On August 9, 2001 President Bush 
arguing that destroying human embryos constituted murder, announced that he would 
allow federal funding only for stem cell lines derived before that date.  The rationale was 
that although the initial embryos had already been destroyed, perhaps the cell lines 
derived from their demise could be used to save lives.  Unfortunately this bill severely 
limited the number of ES cell lines available for research purposes, and curtailed US 
research efforts behind some other countries (Monitoring Stem Cell Research, 1994). The 
state of California became the first to legalize research on embryos, including cloned 
embryos, when Governor Gray Davis signed the new stem cell law SB 253 on September 
23, 2002.   In the state of Massachusetts, on May 31, 2005 an “Act Enhancing 
Regenerative Medicine in the Commonwealth”,  including a chapter on biotechnology, 
passed both the Senate and the House of Representatives legalizing stem cell research. 
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The moratorium on the dispersing of funds for stem cell research in the European Union 
ended on December 31, 2003.  Despite opposing views by member nations, the EU has 
taken the position of funding research on a case by case basis (“EU to Fund Stem Cell 
Research Despite Split,” 2003).  Just last year on August 11, 2004, the United Kingdom 
issued a license to the Newcastle Center for life allowing them to create colonies of 
human stem cells for research (Garfinkle, 2004).  A sensible legal approach loosening the 
current federal restrictions is critical for the US to remain competitive and stay on the 
leading edge of medical innovation.  
 8 
 
PROJECT OBJECTIVES 
 
 The purpose of this IQP was to investigate the controversial topic of stem cells, 
providing information on the various kinds of stem cells and their applications to help 
dispell common myths about their use and potentials.  The effect of stem cell technology 
on society was investigated in via ethical and legal topics.  Finally, the research 
performed help the authors make their own conclusions and recommendations about this 
new technology. 
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Chapter 1:  STEM CELL TYPES AND SOURCES 
 
Stem Cell Definitions  
The term stem cell is used most often by the press when referring to embryonic 
stem cells, which are undifferentiated cells that have been isolated from an embryo.  But 
in reality there are many different types of stem cells with varying levels of potency and 
ability.  All stem cells however must share three common properties. All stem cells must 
be: 1) capable of renewing and dividing for extended periods of time; 2) unspecialized; 
and 3) able to give rise to specialized cells (Stem Cell Basics, 2005). Stem cells are 
unspecialized, meaning that they do not participate in the functions performed by the 
cells that they give rise to. For example, hematopoietic stem cells do not transport oxygen 
through the bloodstream, although they give rise to the blood cells that do.  
When stem cells give rise to specialized cells the process is called differentiation. 
This process is directed by internal signals encoded in the cells genes, and external 
signals which include chemicals, physical interactions with neighboring cells, and 
specific molecules in the cells microenvironment (Stem Cell Basics, 2005). Classically, 
differentiation was thought to irreversible, but recently experiments done transplanting 
the nucleus from certain differentiated cells into an oocyte (the egg) has shown that the 
totipotency of the nucleus can be re-established.  
Unlike many specialized cells, stem cells have the ability to replicate themselves 
an unlimited number of times over the lifespan of an organism.  Normally a cell divides 
into two identical daughter cells, each of which inherits a complete copy of the 
chromosomes from the original cell, this is called symmetric division. Symmetric 
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division occurs in specialized cells and embryonic stem cells, as each daughter cell is an 
exact copy of the parent. Conversely, when an adult stem cell divides one daughter cell 
will become a stem cell (and remain “immortal”) and the other will go through the 
process of determination where it will gain a specific function, this is called asymmetric 
division (Stem Cells… 2001).  Asymmetric division allows for the renewal of specialized 
cells while maintaining a constant supply of new stem cells to continue the cycle.  
 
Stem Cell Potencies 
A stem cell is often described in terms of its potency, or the number of different 
kinds of specialized cells that it has the ability to produce (Figure 1).  The fertilized egg, 
or zygote, is considered to be the ultimate “stem cell” (technically it is not a stem cell 
because it does not renew itself) because it is totipotent, meaning it has the ability to give 
rise to any embryonic or adult tissue cell, including germ cells, the placenta, and 
embryonic membrane. As the zygote continues to divide its potency diminishes. At 
around 5 days, a blastocyst forms consisting of an outer layer and an inner cell mass.  The 
inner cell mass contains embryonic stem (ES) cells.  These cells are pluripotent with the 
ability to make almost all kinds of cells in the body.  An adult human has multipotent 
stem cells capable of making various kinds of cells of one tissue, for example 
hematopoietic stem cells (HSCs) that are capable of forming the cellular components of 
blood.  In addition adults also have unipotent stem cells within certain tissues that are 
usually capable of forming only that same type of cell.  Cells in this category include 
neuronal stem cells, and skin stem cells. 
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Traditionally scientists believed that no adult stem cells were pluripotent, making 
them less useful in medical treatments than embryonic stem cells. However, increasing 
evidence suggests that some adult stem cells, especially those found in bone marrow, 
may retain pluripotency (Sell, 2004). 
 
 
Figure 1. A diagram of diminishing stem cell potency as the 
fertilized egg develops into a specialized adult cell. 
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Stem cells can be found not only in developing embryos but also from the fetus, 
umbilical cord blood, the placenta, and many adult tissues. Scientists hope to use stem 
cells as a form of regenerative and reparative medicine to treat diseases such as 
Parkinson’s, diabetes, and heart disease, as well as countless other types of injuries and 
illnesses.  If procedures can be developed to prepare stem cells from a patient, the stem 
cell treatment would not require another donor, and would avoid the possibility of the 
rejection of tissues, cells, and organs by the recipient (Hwang et al, 2005). Stem cells also 
have to ability to divide indefinitely in culture, meaning that one line of stem cells can 
continue to make new stem cells, thus for example could produce a large amount of skin 
tissue for a burn patient.  
 
Embryonic Stem Cells and Embryonic Germ Cells 
Embryonic stem (ES) cells are defined by their origin in the blastocyst stage of 
the embryo. ES cells are pluripotent, not totipotent because unlike the fertilized egg, ES 
cells cannot by themselves produce a new organism. At this early stage they still have the 
ability to become any of the cells of the human body, but they are not totipotent as they 
can no longer become a part of the embryonic membrane or the placenta. Scientists have 
developed very specific criteria for defining ES cells. Austin Smith, a researcher of 
mouse ES cells, compiled the following list of characteristics necessary for defining ES 
cells: 
           Table I:  Defining Properties of an Embryonic Stem Cell 
 
o a Derived from the inner cell mass/epiblast of the blastocyst 
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o a Capable of undergoing an unlimited number of symmetrical divisions without 
differentiating (long-term self-renewal) 
o Exhibit an maintain a stable full (diploid) normal compliment [complement] of 
chromosomes (karyotype)  
o Pluripotent ES cells can give rise to differentiated cell types that are derived from 
all three primary germ layers of the embryo (endoderm, mesoderm, and 
ectoderm) 
o a,b Capable of integrating into all fetal tissues during development. (Mouse ES 
cells maintained if culture for long periods can still generate any tissue when they 
are reintroduced into an embryo to generate a chimeric animal.) 
o a,b Capable of colonizing the germ line and giving rise to egg or sperm cells. 
o a Clonogenic, that is a single ES cell can give rise to a colony of genetically 
identical cells, or clones, which have the same properties as the original cell. 
o Express the transcription factor Oct-4, which then activates or inhibits a host of 
target genes and maintains ES cells in a proliferative, non-differentiating state. 
o Can be induced to continue proliferating or to differentiate. 
o Lack the G1 checkpoint in the cell cycle. ES cells spend most of their time in the 
S phase of the cell cycle, during which they synthesize DNA. Unlike 
differentiated somatic cells, ES cells do not require any external stimulus to 
initiate DNA replication. 
o Do not show X inactivation. In every somatic cell of a female mammal, one of 
the two X chromosomes becomes permanently inactivated. X inactivation does 
not occur in undifferentiated ES cells. 
(
a
 not shown in human EG cells. 
b
 Not shown in human ES cells. All of the criteria 
have been met by mouse ES cells)   (Stem Cells… 2001) 
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As the zygote divides, the daughter cells produced are called blastomeres. When 
there are about 4-16 cells, they clump together to form a cluster called a morula. When 
number of cells reaches 40-150 blastomeres they form a hollow sphere, or blastocyst, the 
cavity of this sphere is called a blastocoele. The outer cells of the blastocyst, the 
trophoblast, will eventually form the embryonic membrane and placenta, while the inner 
cell mass (ICM) or embryoblast will form the embryo. (Figure 2)  Through the process of 
gastrulation the ICM is then further divided into three germ layers, the ectoderm, 
mesoderm, and endoderm. Each of these layers will eventually develop into all of the 
tissues of the adult organism (Mammalian embryogenesis, 2005). The ectoderm layer will 
develop into skin, dermal appendages, and brain and neural tissue, the mesoderm layer 
becomes connective tissue, muscle, bone and blood vessels, and the endoderm layer gives 
rise to the gastrointestinal tract and internal glandular organs (Sell, 2004). Embryonic 
stem cells are derived from these inner cells of the blastocyst, at an early stage of the 
embryo before it is implanted in the uterine wall (Stem Cells… 2001). 
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Figure 2. The development of the fertilized egg as it divides into 
blastomeres which then form the blastocyst from which embryonic stem 
cells are isolated. 
 
 
Under certain conditions, such as the presence of LIF, leukemia inhibitory factor, 
ES cells can theoretically proliferate indefinitely.  To this point researchers have 
maintained undifferentiated ES cells in culture for more than a year and up to 300 
population doublings.  However, if the ES cells are allowed to clump together to form 
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embryoid bodies they will begin to spontaneously differentiate into different types of 
specialized cells (Stem Cell Basics, 2005).  It is unclear at this time what causes a stem 
cell to remain undifferentiated. Transcription factors such as Oct-4, expressed by human 
and mouse ES cells in vivo, as well as the cell cycle of the cell, are thought to play a role 
in maintaining the stem cells undifferentiated state.  
Embryonic germ (EG) cells are isolated from the embryo or fetus, specifically 
from the gonadal ridge, and eventually form the germ cells of the organism. EG cells, 
derived from the primordial germ cells found in the gonadal ridge, are closely related to 
ES cells. Both are pluripotent, replicate for an extended period of time, and generate both 
male and female cell cultures.  However, EG cells cannot be maintained in culture as 
long as ES cells and they do not produce teratomas, which are germ cell tumors made up 
of cells from all 3 germ layers, when injected into colonies of mice cells with 
compromised immune systems (Stem Cells… 2001).  
Although ES and EG cells are the most potent type of stem cells known at this 
time, there is an ongoing debate about whether or not their potential in medicine should 
be further researched.  Because the isolation of ES cells requires the destruction of an 
embryo or fetus, many view the scientific exploration of their properties and uses as 
unethical. 
 
Adult Stem Cells 
Adult stem cells, or somatic stem cells, are unspecialized cells that are found in 
specialized tissues, unlike ES cells they are not pluripotent, they only become specific 
types of cells.  Although they are not pluripotent, adult stem cells do allow for tissue 
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renewal and growth.  These stem cells are theorized to be located in certain areas of each 
tissue where they do not divide until they are triggered by injury or disease (Stem Cell 
Basics, 2005). They serve to maintain the constant functioning of the organism and, to an 
extent, to replace cells that die (Stem Cells… 2001).  Adult stem cells, in comparison to 
other cells in the body, are rare.  Only a small population of them can be found in adult 
tissues, and their origin is still uncertain in most tissues. Adult stem cells have been found 
in numerous places throughout the body, including the brain, bone marrow, peripheral 
blood, skeletal muscle, the spinal cord, blood vessels, dental pulp, retina, liver, pancreas, 
cornea, and epithelia of the skin and digestive system (Stem Cells… 2001). 
Adult stem cells enter “normal differentiation pathways” where they divide and 
mature, eventually generating specialized cells specific to their type.  The pathways of 
various kinds of adult stem cells are outlined as follows in Stem Cell Basics by the 
Department of Health and Human Services: 
 
Stem Cell Source Types of Cells Produced 
Hematopoietic  
All types of blood 
cells 
Red blood cells, B lymphocytes, T lymphocytes, 
natural killer cells, neutrophils, basophils, eosinophils, 
monocytes, macrophages, and platelets 
Bone Marrow 
Stromal 
(mesenchymal)  
 
Connective tissues 
Tendons, osteocytes (bone cells), adipocytes (fat 
cells), and chondrocytes (cartilage cells) 
Neural  
Parts of the nervous 
system 
neurons, astrocytes, and oligodendrocytes 
Epithelial  
Lining of the digestive 
tract 
Absorptive cells, goblet cells, Paneth cells, and 
Enteroendocrine cells 
Epidermal  
Basal layer of the 
epidermis 
Keratinocytes (forms the protective layer of the skin) 
Follicular  Base of hair follicles Hair follicles and the epidermis 
Hepatic Liver Hepatocytes 
Table 1. The normal differentiation pathways of adult stem cells. 
 (Stem Cell Basics, 2005) 
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Adult Stem Cell Plasticity 
Adult stem cells are normally thought to be “committed” to differentiating into a 
certain type of cell, but as mentioned earlier, recent experiments have suggested that even 
adult stem cells may retain some plasticity.  Plasticity is the ability of a stem cell from 
one tissue to produce a differentiated cell of another type of tissue. This phenomenon 
reinforces the theory that some adult stem cells retain pluri/multi-potency throughout the 
life of the organism.  
Some examples of this plasticity include hematopietic stem cells that are able to 
differentiate into the three major types of brain cells, skeletal muscle cells, cardiac 
muscle cells, and liver cells, bone marrow stromal cells that are able to differentiate into 
cardiac and skeletal muscle cells, and brain stem cells that are able to differentiate into 
blood cells and skeletal muscle cells (Figure 3).  If this plasticity can some day be 
controlled it could lead to new treatments where diseased or injured tissues can be 
replaced by healthy tissue (Stem Cell Basics, 2005) without having to use ES cells from 
embryos. 
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Figure 3. Diagram of plasticity in non-human adult stem cells  (Stem Cells.. 2001). 
 
 
Adult Stem Cell Isolation 
Scientists hope to grow adult stem cells in culture and learn how to direct them to 
produce certain cell types that can be used to treat specific diseases or injuries, such as 
insulin producing cells for diabetics.  It is difficult to identify adult stem cells, especially 
in vivo because it is nearly impossible to show that the cell is self-renewing throughout 
the entire life of a complex organism or that it is clonogenic, meaning that is able to 
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divide and produce a line of identical cells. Adult stem cells do not have the specific 
criteria as embryonic stem cells to identify and classify them, but certain methods have 
been developed by researchers to distinguish them from other types of cells. Often one of 
the following three methods is used: 1) labeling the cells with molecular markers and 
then determining the specialized cells they produce; 2) transplanting labeled cells from 
one living animal to another to determine if the cells repopulate their tissue of origin; and 
3) isolating and growing the cells in culture and manipulating them to determine what 
types of cells they can generate (Stem Cell Basics, 2005).  
 
Adult Hematopoietic Stem Cells 
There are 5 sources of hematopoietic stem cells (HSCs): 1) bone marrow, 2) 
peripheral blood, 3) umbilical cord blood, 4) blood from the fetal hematopoietic system, 
and 5) ES and EG cells as they can potentially be manipulated to give rise to any kind of 
adult stem cell (Stem Cells… 2001).  HSCs are most commonly isolated from bone 
marrow.  They are responsible for the production on all of the types of blood cells found 
in the body.  Of all of the different kinds of adult stem cells, HSCs are currently the best 
understood and the only kind of stem cell that is routinely used as treatment for cancer 
and other disorders affecting the blood and immune system. HSCs have been studied for 
over 50 years and the first successful bone marrow transplant in the United States took 
place in 1968.  The first successful transplant between an unrelated donor and recipient 
was is 1973.  Few members of the general public know that stem cells have been 
effectively used to treat diseases for over 30 years (History of Stem Cell Transplants, 
2005).  Originally HSCs were used in bone marrow transplants where the recipients own 
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hematopoietic system is irradiated to wipe out their own blood-producing cells and 
replaced with bone marrow from the donor. About 1 in every 10,000 to 15,000 cells in 
the bone marrow and 1 in every 100,000 in the peripheral blood is thought to be a 
hematopoietic stem cell.  Now that a method of using a cytokine to urge the stem cells to 
migrate out of the marrow has been developed, peripheral blood is commonly used as it is 
a less invasive procedure.  ES and EG cells as well as fetal blood are not currently used in 
HSC treatment due to the ethical issues that they incur.  
 
Umbilical Cord Stem Cells 
 Stem cells isolated from the umbilical cord have the same multipotency as bone 
marrow HSCs, but do not have the potency of ES and EG cells, and the controversy of 
destroying an embryo is avoided. Although there have been suggestions of cord blood 
containing multipotent stem cells, to this point only hematopoietic cells have been 
identified. Stem cells from cord blood differ from those found in the bone marrow and 
peripheral blood:  the potential for HSC’s to repopulate the hematopoietic system after 
transplants tends to decrease as the cells age, thus cord HSCs are “younger” than marrow 
HSCs, and HSCs found in the umbilical cord are less likely to cause immune reactions in 
the recipient.  In this way cord blood seems advantageous to other sources of HSCs, 
however, cord blood does not yield enough stem cells to use in an adult transplant, so 
some labs are developing ways to amplify cord HSCs for treating adult patients (Viacell, 
2002). 
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Parthenotes 
A possible alternative source of embryonic stem cells has recently been 
discovered.  In certain invertebrate species (such as ants and bees) the female is able to 
reproduce without male fertilization, this is called parthenogenesis.  Worker bees and ants 
are produced by this process.  Parthenogenesis does not happen naturally in more 
complex organisms, such as humans, but it can be induced artificially.  Scientists have 
used chemicals to imitate the fertilization of the egg by sperm, causing the egg to divide 
on its own (without eliminating half of its chromosomes) and develop into something 
very much like a normal embryo.  In mammals the embryo that results from this 
treatment never develops past the early stages of the fetus, meaning they have no 
potential to become a living organism, they do however develop into a blastocyst from 
which ES cells have been derived in monkeys (Cibelli et al, 2002).  The egg normally 
contains a full set of chromosomes until fertilization, when half of the chromosomes are 
expelled and the other half of the chromosomes are then supplied by the sperm, if this 
process of elimination is suppressed the egg will contain the full number of 
chromosomes. If the chromosomes from the egg are completely replaced by 
chromosomes from two of a male’s sperm cells a male parthonote can also be created.  
Researchers have found that female parthenotes tend to generate brain and nerve cells, 
while male parthenotes tend to generate muscle cells (Pollack, 2001).   
Scientists have successfully induced parthenogenesis in human eggs that 
developed to the blastocyst stage (Cibelli et al, 2001) but no human parthenote ES cell 
lines have been established yet.  Parthenogenesis was induced in 77 macaque monkey 
eggs, and out of those one yielded a stable line of pluripotent stem cells (Cibelli et al, 
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2002; Holden, 2002).  Researchers were then able to manipulate these stem cells into 
generating neurons, smooth muscle cells and heart-like cells (Parthenogenic Stem 
Cells…2002).  At this time there are many unanswered questions about the usefulness of 
the stem cells isolated from parthenotes. Without the influence of both male and female 
chromosomes that mammals require it is possible that the stem cells will not develop 
normally, and some scientists doubt that they will prove useful in therapeutic cloning 
(Weiss, 2001).  Parthenotes, if found to be a reliable source, seem to be an answer for 
resolving the ethical debate over embryonic stem cells, however new arguments have 
arisen around the religious association to “virgin births” and the public’s possible 
uneasiness with women donating eggs for this purpose and “the idea of producing a 
creature whose status as a life-form is entirely ambiguous” (Holden, 2002).   
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CHAPTER 2:  STEM CELL APPLICATIONS 
 
The human body houses approximately 220 different types of cells.  These cells, 
when functioning properly, do their part to make the human body work as a fairly 
efficient machine.  When even one type of cell does not appear to be in good working 
order, it is visibly evident in the health of the individual.  It usually does not require a 
doctor to diagnose a person with some sort of disorder, but it would require one to 
explain and correct it.  An attack on one type of cell could leave someone with a faulty 
nervous system or faulty heart, for example.  Many of the problems are easily fixed 
through a surgery or some sort of antibiotic; but there are a handful of diseases that still 
leave doctor’s scratching their heads. 
Leukemia can be corrected through a long, arduous process.  As far as diabetes is 
concerned, doctors are usually able to keep it in check as long as the patient takes their 
medicine regularly and on time.  Parkinson’s disease and cancer only sometimes respond 
to current therapies.  As time passes, efforts are constantly made to identify new leads in 
cracking these puzzles.  So complex are these puzzles that not even MENSA candidates 
could possibly decipher them.  In the past few years, researchers have been able to 
elaborate greatly on the idea of stem cell research being the missing key in cracking the 
code for certain diseases and saving millions of human lives.  The idea may have started 
out as a long-shot, but has quickly become the frontrunner in eradicating some of the 
world’s more resilient diseases. 
These diseases cause mutations in the body’s cells making them act in a certain 
way as to disrupt the body’s natural working order.  In some cases, these diseases are 
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hereditary with a person’s DNA containing the code for these diseases.  DNA is a puzzle 
of its own with different sequence making a very unique masterpiece.  When a disease 
mutates a piece or pieces of this masterpiece, there is a need for a correction to that piece 
or pieces.  Stem cells can make that correction in order to restore the masterpiece that 
once was to its original working order.  While research is being done to verify this 
hypothesis in human embryonic stem (ES) cells, we have already seen strong evidence 
that success can be achieved in humans with adult stem cells, or in animals with ES cells. 
 
 
Hematopoietic Stem Cells and Leukemia 
It is untrue that stem cells have yet to save human lives.  The hematopoietic stem 
cell (HSC) has been used for many years in Leukemia patients to send the Leukemia into 
an ultimate remission.  This type of stem cell can be found in bone marrow.  As discussed 
in chapter 1, HSCs are multipotent, capable of generating all the various cellular 
components of the blood (figure 1).  Since leukemia is a blood cell disease, it is a logical 
choice for HSC treatment.  The HSC is capable of replicating for the entire life of the 
organism.  A bone marrow registry has been setup for those Leukemia patients that may 
need a transplant to survive.  The transplant calls for a donor match so none of the cells 
are rejected by the patient’s immune system.  Once the patient’s bone marrow has been 
destroyed by radiation or chemotherapy, the new marrow HSCs replicate making red 
blood cells and white blood cells, all of which help in constant body maintenance. 
Recently this process has been refined using HSCs isolated from umbilical cord 
blood.  Cords are donated by the mother at time of birth, and the blood is frozen for 
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storage.  Cord HSCs are more abundant than in bone marrow, and they are less likely to 
be rejected by the patient. 
 
Figure 1: Diagram of Hematopoiesis, the Formation of Blood Cells by HSCs.  The top lineage illustrates 
the differentiation possibilities for HSCs, while the bottom lineage illustrates the differentiation 
possibilities available for stromal stem cells (Hematopoietic Stem Cells, 2005). 
 
  
Embryonic Stem Cells 
A more powerful form of relief is contained within embryonic stem cells.  
Although this method is highly controversial, the possibilities that lie within the heart of 
these cells are multitudinous in number.  ES cells are the master cells that can 
differentiate into almost any type of cell in the human body.   
While these cells are pluripotent, human life is too fragile to experiment with.  
Scientific testing usually begins with lab animals, mostly mice.  Scientists have been able 
to culture mouse embryonic stem cells in the presence of low insulin concentrations.  
This prompted the cells to increase their insulin production almost sevenfold (Stem Cells 
and Diabetes, 2005).  Therefore, ES cells seem to provide more of a hope in the fight 
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against the world’s more threatening, and seemingly unbeatable, diseases.  Their 
versatility is surpassed by nothing else.  Lung cells, heart cells, liver cells, and muscle 
cells all can emerge from ES cells.  Theoretically, this is the ultimate utility tool for 
fixing our fragile frames. 
Diabetes 
 In the United States alone, approximately 18.2 million people have diabetes.  Of 
those 18.2 million, 13 million are actually diagnosed with some form of diabetes; while 
the other 5.2 million are unfortunately unaware (All About Diabetes, 2005).  A person 
who suffers from diabetes cannot produce a hormone called insulin. It is also possible 
that they can produce the insulin but the body may misuse it.  Insulin in the body is used 
to convert sugars, starches and foods into energy (All About Diabetes, 2005). 
 Insulin  is normally produced in the beta islet cells of the pancreas (Figure 2)  
Scientists, one day, hope to be able to coax ES cells into differentiating into insulin-
producing beta cells (Kahn, 2005).  The belief is that the effect of new, working beta cells 
will work as if they had been there the entire span of the patient’s life.  Once the cells 
have matured into pancreatic beta cells, they will begin to secrete insulin that will 
hopefully prove enough to control, and maybe eliminate, type 1 diabetes (Kahn, 2005).  
There is, however, a slight obstacle in following this line of thinking.  Type 1 diabetes is 
an autoimmune disease.  It can destroy new beta cells should they appear from a donor.  
This is not say that it will definitely happen every time a beta cell is transplanted to a 
person with type 1 diabetes.  There have been plenty of successful transplants. This 
method is, unfortunately, limited due to a short supply of donors.  There are about three 
to five thousand donors compared to the approximate 800,000 people diagnosed with 
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type 1 diabetes (Kahn, 2005).  Recent ideas also focus on encapsulating the islet cells to 
prevent their destruction in the host from the autoimmune attack. 
  
Figure 2. Insulin Production in the Human Pancreas.  The pancreas is located in the abdomen, adjacent to 
the duodenum (the first portion of the small intestine). A cross-section of the pancreas shows the islet of 
Langerhans which is the functional unit of the endocrine pancreas. Encircled is the beta cell that 
synthesizes and secretes insulin. Beta cells are located adjacent to blood vessels and can easily respond to 
changes in blood glucose concentration by adjusting insulin production. Insulin facilitates the uptake of 
glucose, the main fuel source, into cells of tissues such as muscle (Stem Cells and Diabetes, 2005). 
 
 
With transplant relief in such short supply, we are forced to find new ways of 
therapy that can allow for the supply to last a while longer.  Researchers have had some 
success with obtaining islet cells from an adult cadaver and teasing them to express the 
PDX-1 gene, a characteristic gene of insulin-producing beta cells.  A great deal of 
engineering is necessary for this step, but nothing is too much if it works in the end.  The 
Beta Cell 
Glucose 
Pancreas 
Insulin 
Muscle Fiber 
Blood 
Vessel 
Islet of 
Langerhans 
 29 
big question with this method is under what conditions can these cells be cultured and 
coaxed into becoming efficient insulin secretors (Stem Cells and Diabetes, 2005). 
The keyword here is efficient.  Ron McKay and his colleagues were able to 
culture mouse ES cells into producing insulin; but, once introduced into a diabetic mouse, 
they were unable to reverse the diabetes. The silver lining to the experiments was that the 
cells did remain insulin producing cells, they just could not produce enough of the insulin 
needed for reversal (Stem Cells and Diabetes, 2005).    
It is also possible to culture cadaver cells but it has been found through study that 
the cells that proliferate well don’t produce insulin, and the ones that don’t proliferate are 
very efficient insulin secretors.  Ammon Peck, Vijayakumar Ramiya and their colleagues 
have recently been able to perform this procedure with the use of adult mouse cells.  
They were able to obtain islet-like clusters that consisted of the four main components 
excreted from the pancreas— insulin, glucagon, somatostatin, and pancreatic 
polypeptide.  When these four substances were found to be present, it was not too long 
afterwards that the diabetes was reversed (Stem Cells and Diabetes, 2005). 
 Type 2 diabetes is unique in that it does not hurt the insulin-producing cells; but, 
rather, it is unaffected by the presence of insulin.  It would appear that stem cell research 
cannot be of much assistance to the 90% of the people in the United States who are 
diagnosed with type 2 diabetes, never mind the entire world (Kahn, 2005).  The prospects 
for alleviating type 1 diabetes, however, are not too far off in the future.  The next 
obstacle seems to be overcoming the autoimmune system, and an answer may already be 
in the woodwork.  Before transplantation, it’s possible to dip the cells into a 
nonimmunogenic material so as to hide the cells from the body’s immune system, 
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eliminating the need for the patient having to take immunosuppressant drugs for the 
duration of their life (Stem Cells and Diabetes, 2005). 
 
 
Adult and ES Stem Cell Therapy of the Nervous System 
If you were to get a cut, it would heal. It may take a few days, but it would heal.  
If you and your girlfriend or boyfriend broke up, you might be sad for a while; but, 
eventually, you would be fine again.  Somewhere through the ages of time, the phrase, 
“Time heals all wounds”, was coined.  Would the person who coined that phrase feel a 
little outdone when they look at degenerative nervous system diseases and how time 
cannot possibly cure them?  As of now, there are still many unanswered questions on the 
path to finding a cure.  The adult nervous system is only capable of small scale 
renovation, so when major damage happens like a large stroke or a disease such as 
Parkinson’s disease or Alzheimer’s diseases, whatever was damaged stays damaged.  
Recently, scientists have found a ray of light amongst the shadows that surrounded these 
debilitating illnesses.  Neural stem cells have been found in the body, and researchers 
hope that maybe they can be of some assistance. 
 
Parkinson’s Disease 
 Parkinson’s disease is a disorder that occurs when nerve cells in the substantia 
nigra part of the brain either become impaired or die (About Parkinson’s Disease, 2005).  
The substantia nigra is located in the middle region of the brain (Substantia Nigra, 2005) 
(Figure 3).  This part of the brain is very important in that it allows for smooth 
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functionality of the body’s normal physical 
movements.  It produces a chemical named 
dopamine to accomplish this task.  Should the cells 
cease to make the dopamine, or at least 80% of the 
dopamine-excreting cells, symptoms of Parkinson’s 
disease-- Tremors, stiffness and slowness of 
movement, to name a few-- will become evident 
(About Parkinson’s Disease, 2005). 
 As of now, scientists have only been able to produce drugs that can temporarily 
ease the symptoms of Parkinson’s disease.  One of the most common treatments for this 
ailment is a drug known as Levodopa.  The brain is able to change this drug into 
dopamine.  Unfortunately, this is not a permanent solution.  It works tremendously, 
initially; but as treatments using levodopa continue, the drug becomes less and less 
effective and the side effects become greater and greater (Rebuilding the Nervous System 
with Stem Cells, 2005).  It’s easy to say, not having experienced the disease; but it would 
appear that this is a losing battle in the fight against Parkinson’s disease.  A more drastic 
step in the fight against Parkinson’s would be brain surgery (About Parkinson’s Disease, 
2005). It’s not unheard of, but it is a step which must be carefully planned and carefully 
researched.  A neurologist and a brain surgeon must be contacted and they both must 
specialize in Parkinson’s.  In the end it still only eases the symptoms (About Parkinson’s 
Disease, 2005). 
 While it is comforting to know that there is some form of relief from this disease, 
it is still puzzling to realize that there has to be a way to put a stop to it all at once.  
Figure 3. The Substantia Nigra 
(Substantia Nigra, 2005) 
 32 
Scientists are looking towards two promising ideas that could bring an end to the 
helplessness that Parkinson’s.  The first is cell transplantation which involves implanting 
fetal cells and tissues (which include neuronal stem cells) into the brain to allow them to 
finish growing and inserting themselves into the patient’s brain to produce dopamine.  
There have been mixed results with this method with many cases of improvement in a 
patient’s condition (Rebuilding the Nervous System with Stem Cells, 2005). 
While there have been rather noteworthy efforts using that fetal cell transplant 
technique, the public is strongly against using fetal cells for anything because fetal cells 
are even more mature than the blastocysts used to obtain ES cells, so the public argues 
they have higher moral status.  Also, scientists would really like to know whether the 
cells can replicate to produce more dopaminergic neuronal cells to keep the patient free 
and clear of Parkinson’s for the duration of their life.   
The second method that scientists are researching at the moment is isolating and 
growing the recently discovered adult neuronal stem cells and implanting them in a 
patient’s brain to be allowed to differentiate into dopamine-producing cells.  This is 
exciting and it sounds like it is exactly what a doctor would order if they could order 
something to fix up this problem.  The biggest obstacle, however, lies in culturing 
neuronal stem cells.  They are very difficult to culture in a lab, at least not without some 
form of engineering being performed on them (Rebuilding the Nervous System with 
Stem Cells, 2005).   
Well, when in doubt, look to the pluripotency of embryonic stem cells to save the 
day.  In 1998, Ron McKay, of the National Institute of Health, and his colleagues were 
reported being able to culture and expand a group of neurons made from mouse 
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embryonic stem cells.  These neurons found their way into the brain of an adult rat with 
Parkinson’s.  The results of this experiment show a great improvement in the rat’s 
condition and a recession of the disease (Rebuilding the Nervous System with Stem 
Cells, 2005).  Human testing cannot be too far into the future. 
 
Adult and ES Stem Cells and the Heart 
 The heart is the driving force behind our very being.  Should it cease to work, we 
would cease to exist.  It is a well-oiled machine, when working properly.  The heart 
pumps the blood throughout the body. If the pathways, or blood vessels, were to become 
impassable, important parts of the body would not be able to get the necessary nutrients 
needed to function correctly.  When that happens, the heart must force itself to work 
harder and harder to push the blood past whatever is blocking its path.  If the blockage 
were to happen in the heart, the heart’s muscle cells, cardiomyocytes, would die off.  If 
too many of them die off, a myocardial infraction occurs.  Simply put, you would get a 
heart attack. Approximately 1.1 million people die from heart failure in the United States 
each year (Can Stem Cells Repair a Damaged Heart, 2005). 
 Imagine a world where congestive heart disease can be corrected after first onset.  
Generally, we are supposed to take care of our bodies so that heart disease and heart 
failure can be prevented, but these things happen and it is not always preventable.  Heart 
disease can also be brought on by reasons such as hypertension (Can Stem Cells Repair a 
Damaged Heart, 2005).  Researchers are currently exploring the possibility of using 
embryonic and adult stem cells to repair damage done to cardiomyocytes.  The obvious 
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choice would be to start with the embryonic stem cells; but, in this case, that would be an 
incorrect assumption (Can Stem Cells Repair a Damaged Heart, 2005). 
 On February 17, 2003, sixteen year old Dimitri Bonnville underwent therapy for 
his heart attack after open heart surgery for an impaled nail from a nail gun.  His parents 
were given the choice for a heart transplant or an experimental procedure involving stem 
cell therapy.  Seeing the low risk versus great rewards attractiveness of the experimental 
procedure, his parents opted for the stem cell therapy.  He was given drugs to coax his 
body to produce extra adult stem cells and after four days of production, these stem cells 
were harvested from his own blood stream with the use of a heart catheter.  They were 
then injected into the bloodstream that supplies blood to the front of his heart, the part of 
his heart that was heavily damaged.  Scientists didn’t even need to worry about the 
immune system rejecting the cells because they were his own.  One week following the 
treatment, he was released from the hospital and was finishing his recuperation in his 
home (Philipkoski, 2003). 
 This may be one isolated incident, but it may have been the spark needed to 
propel this portion of stem cell research.  Sensing the potential in this field, Dr. Joshua 
Hare decided to spearhead a study at the Johns Hopkins Hospital in Baltimore, Maryland.  
Forty-eight patients will check in and they will participate in a study that will test the 
effects of adult stem cells on damaged areas of the heart.  When the test was run on pigs, 
the experiment ran beautifully. Out of fourteen pigs, all with heart problems, half were 
given adult stem cells and the other half was given a placebo.  The pigs that were given 
the adult stem cells had healed almost all of the scar tissue and had returned the heart 
contractions back to normal.  Those that were given the placebo actually worsened in 
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their condition and eventually died (Trials to test safety of stem cell therapy for heart 
damage, 2005). 
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CHAPTER 3:  STEM CELL ETHICS 
 
Stem cells, although they carry with them a great potential power, also carry a 
great deal of ethical roadblocks, some types more so than others.  Considering what is 
involved in working with stem cells, many people feel that certain types of work should 
be deemed unethical, immoral and, in some cases, murder.  There has not been a situation 
this hotly debated for this length of time since Roe versus Wade, which still owns the 
title.  From chapter 1, we know there are several types of stem cells. There are adult stem 
cells (such as hematopoietic stem cells, neuronal stem cells, stromal stem cells, and 
epithelial stem cells, etc) and embryonic stem (ES) cells. The latter are usually isolated 
from a blastocyst (an embryo about 5 days old, the size of the period at the end of this 
sentence), which has potential to become an adult, so some call its destruction murder. 
In a more liberal world, researchers would have proposed that stem cells can 
cancel out diseases such as those discussed in chapter 2, and the entire nation would have 
stepped aside allowing their use arguing that researchers know more about this subject 
than the common individual.  However, the world we live in allows scientist’s work to be 
regulated by even the tiniest of voices.  These voices, even though they are heard in the 
streets, can carry all the way to governmental offices. 
 
The Present Policy 
On August 9, 2001, President Bush took a stand on the issue of federal funding 
for stem cell research.  He decreed that from that point forward, no new embryonic stem 
cell lines were to be opened. What that meant was that scientists and researchers would 
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not be able to obtain embryos from donors and use them for research purposes.  The only 
embryos, at this point, that can possibly be used in this manner would be those obtained 
prior to the date of our present policy (Monitoring Stem Cell Research, 2004).  The 
rationale, as we will discuss more in chapter 4 Stem Cell Legalities, is although the 
blastocysts were destroyed to obtain the ES cell lines, perhaps those existing cell lines 
can be used to save lives.  The past cannot be tampered with. The administration, 
however, will not be a part of furthering the supply by lending federal funds for 
destroying more embryos.  So the ethical debate for ES cells centers on whether the 
destruction of a blastocysts constitutes murder.  To answer this question, we turn to the 
world’s four major religions to see their stance on when life begins. 
 
Number of Embryos Destroyed versus Lives Saved 
Maybe it is possible that the general public is unaware of the awesome power that 
is at our disposal with stem cells.  One human embryo can produce about forty stem cells 
(Weiss, 2005).  As of the present moment, there is a huge fight about what to do about 
the approximate 400,000 frozen embryos that are in storage inside in vitro fertilization 
clinics (Freking, 2005).  It is a stretch, but here is a crazy idea.  We could use them to 
save someone’s life from an unpleasant and abrupt end.  In Seoul, South Korea, scientists 
have come up with a new method for the use of hES cells.  Their original method used 
about 242 cells.  Their new and improved method has cut this from 242 down to the use 
of about 20 hES cells (Scientists match stem cells to patients, 2005).  Their work has 
been proven to be effective in human testing.  The math works out to being able to save 
approximately 800,000 people.  Call it a crazy idea, or even insane, but the numbers 
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speak for themselves.  Those forty hES cells can be cultured in a medium and under the 
right conditions can produce millions of healthy cells and can replicate infinitely.  The 
number of people that can be saved from these cells would be endless. 
The thought of 400,000 lives being destroyed is a sore sight, from a conservative 
view.  So if you look closely, every embryo has the potential to save multiple lives.  
Since the argument being thrown against the researchers is that we should not destroy 
nascent human life, why should we throw away existing lives for the sake of one 
potential life the size of a dot.  All efforts until now have been the equivalent of a band-
aid for a broken leg.  Being allowed to complete this stem cell research would be the 
equivalent of mending the broken bone on the spot and the person being able to walk 
away. 
 
Religious Stances on Stem Cells 
Hinduism  
 The traditional Hindu belief is that life begins at conception, which is the point 
when a person is reborn from their previous life, or reincarnated.  Some believe that 
‘ensoulment’ or the beginning of personhood takes place between the 3 and 5 month of 
gestation.  However, Swami Tyagananda, a Hindu chaplain at the MIT Religious 
Activities Center, argues that ES cell research and therapy may be justifiable as it is 
considered an “extraordinary, unavoidable circumstance,” and an act done “for the 
greater good”( Reichhardt, 2004).  While abortion and any other kind of killing of the 
fetus at any stage is considered murder, abortion is still practiced in Hindu culture in 
India because of the cultural preference for boys.  
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Islam 
 Traditional Muslim belief supports ES cell research for forty days after 
fertilization.  Most Muslim’s believe that it is after the blastocyst stage when the fetus 
becomes a person, and that ‘ensoulment’ is a developmental process that does not occur 
at the moment of conception.  Although the embryo and fetus are considered sacred, and 
it is not acceptable to abort them, under certain circumstances it is permissible to use 
them to benefit the human population.  
 Studies done by the Islamic Institute polling the opinions of Muslim Americans 
show that the majority of the Muslim community in the United States supports ES cell 
research (Figure 1).  Through the Islamic method of forming an opinion about 
controversial matters, ijtihad, where a panel of “qualified Islamic scholars” review 
current research, and through careful consideration decide on a position that conforms to 
Muslim belief (The Islamic Institute, 2001), it was decided that stem cell research should 
proceed.   Although Muslim teachings inherently reject human cloning experimentation, 
the process of IVF is generally seen as a, “compassionate and humane scientific 
procedure to help infertile couples bear children,” but only when they are preformed 
under strict guidelines, including that the couple must be married (The Islamic Institute, 
2001).  Because this procedure inevitably produces spare embryos, the Islamic Institute 
not only supports using these embryos as a source of ES cells, but feels that it is a, 
“societal obligation” (The Islamic Institute, 2001). 
 40 
 
Figure 1. Poll of Muslim American’s Opinion on ES Cell Research (The Islamic Institute, 
2001). 
 
Judaism 
 Judaism also teaches that life is acquired progressively; the embryo is not given 
human status until the 40th day of gestation (well past the blastocyst stage), once the 
embryo begins to take human form (Green, 2001b).  The Union of Orthodox Jewish 
Congregations stated that, “an isolated fertilized egg does not enjoy the full status of 
personhood” (Religious Views…2001).  In fact, some Jews believe that ‘ensoulment’ is 
not achieved until the moment of birth.  So, while it is wrong to unnecessarily abort a 
fetus, it cannot be considered murder.  However, an abortion is permitted if carrying the 
child is a threat to the mother’s health or if the fetus is “severely defective” or has a 
terminal illness (Dorff, 2002).  In fact, due to Judaism’s emphasis on protecting and 
healing the body, “an abortion must be performed to save the life or the physical or 
mental health of the woman, for she is without question a full-fledged human being with 
all the protections of Jewish law, while the fetus is still only part of the woman’s body” 
(Dorff, 2002). 
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The Jewish faith also places a strong emphasis on human healing (Ayon, 2002). 
“What would be ‘immoral and unethical’ is cutting off funds for promising medical 
research,” says The Religious Action Center of Reform Judaism (Religious 
Views…2001).  Judaism views our ability to heal as a gift from God and by not utilizing 
this gift is, “turning God down” (Ayon, 2002). 
This support is conditional however; the embryo from which the stem cells are 
isolated must be aborted legitimately under Jewish law.  They also support the use of 
excess embryos from IVF procedures, as embryos formed outside of a woman’s body 
have an even lower status than those in the first 40 days of gestation (Dorff, 2002).  The 
subject of creating embryos specifically for research purposes is more difficult.  Some 
Jews feel that this should never be permissible, while other believe that it can be 
permitted under the condition that the woman only does this once or twice in her life due 
to the increased risk of developing ovarian cancer from drugs causing hyper-ovulation 
(Dorff, 2002). 
 
Christianity 
 Some Christians approve of ES cell research under certain conditions, while 
others believe that it is unethical under any circumstances. The majority of Christians 
believe that life begins at conception and is sacred from that moment on.   
Catholic officials are strictly opposed to the destruction of embryo’s under any 
conditions, ES cell research is “immoral, illegal, and unnecessary,” as said by the U.S. 
Roman Catholic Bishops (Religious Views…2001).  Catholicism is the only major 
religion that is opposed to the in vitro fertilization (IVF) methods which, along with 
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cloning, are the main sources for ES cells.  The IVF clinics often destroy excess embryos, 
and these embryos could be used as a source of ES cells. This is a popular method for 
allowing infertile couples to have children, however, the Catholic Church believes that it, 
“breaks the God-given connection between sex and procreation” (Reichhardt, 2004). 
The position of Protestant denominations ranges from the Southern Baptist 
Convention, who believe that the embryo is the “tiniest form of human life and should 
not be destroyed,” to the American Presbyterian Church, who support ES cell research, 
“if the goals cannot be reached in any other manner” (Green, 2001b).   Although the 
group itself has no official position on stem cell research, the president of the Unitarian 
Universalist Association, William Sinkford stated his belief that there should not be a ban 
on stem cell research, but, “no human embryos should be created specifically for stem-
cell experimentation, thus turning human life and human reproduction into a commodity 
— surely a clear affront to our first principle affirming the inherent dignity of human 
beings" (Reichhardt, 2004). 
Even those Christians that do not believe that the embryo is fully human argue 
that they are still, “deserving of respect”.   Nigel Cameron, a bioethicist at the Institute on 
Biotechnology and the Human Future in Chicago, Illinois, and an evangelical Christian 
believes that, “It is by no means necessary to take the view that the early embryo is a full 
human person in order to be convinced that deleterious experimentation is improper" 
(Reichhardt, 2004). 
Thus in the end, three of the worlds four main religions and some Christians agree 
that working with ES cells is ethical so long as the cells are used to help save lives, and 
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so long as the embryos used to obtain them were not produced exclusively for that 
purpose.  
 
Opposition’s Views on Embryonic Stem Cell Research 
 Immoral, attack on innocent life, a form of abortion; these are phrases that can be 
heard throughout the streets.  Embryos deserve a chance to become human life.  Who are 
we to say that they are not to be allowed to live?  We are not here to play God. 
 The Catholic Church stands against this research that utilizes and destroys the 
embryos.  No price can be put on human life, living or nascent.  These embryos can 
become a human life; and, therefore must be protected as if it already were a human soul.  
We have been put on this Earth to be fruitful and multiply.  We are negatively 
contributing to the second part of that charge if we were to allow the research done upon 
these embryos.  In a meeting with President Bush on July 23, 2001, the Pope stated, “In 
defending the right to life, in law and through a vibrant culture of life, America can show 
the world the path to a truly humane future in which man remains the master, not the 
product, of his technology (Pope John Paul II Addresses President Bush, 2001).”  We 
should all heed these words, especially the part about being the master of our technology 
and not the product of it. 
 
Parthenote Ethics 
 Parthenotes are eggs, embryos, or individuals that are created without 
fertilization.  In a lab setting, parthenotes are created by chemically treating eggs so cell 
division initiates.  Parthenotes appear to be the ideal answer to the stem cell debate, if 
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they prove to be a viable source of human ES cells.  Regarding mammalian parthenotes, 
parthenote blastocysts have already been created in monkeys (Cibelli et al, 2002) and 
man (Cibelli et al, 2001), but so far ES cells have only been derived from parthenote 
blastocysts in monkeys (Cibelli et al, 2002).  Mammalian parthenotes do not have the 
ability to develop past the early blastocyst stage, so they can not make an individual, thus 
they have lower moral status than an embryo obtained by fertilization.  They do 
theoretically give rise to ES stem cells, although whether these stem cells could be 
successfully used in medical treatments has not been proven.   
Three of the world’s four main religions fully support the use of parthenote 
blastocysts as an alternative source of ES cells.  Some in the Catholic Church are the 
exception, although not all Catholics agree.  This support is based on the premise that no 
mammalian parthenote could ever develop past the blastocyst stage.  Because parthenotes 
do not develop past this stage they have less moral status than embryos produces by 
fertilization.  If scientists find a way to make mammalian parthenotes develop past this 
stage to become a fetus or be born, their moral status would increase and the validity of 
using parthenotes as an ethical alternative to embryos would need to be reassessed.  
Those in the Catholic Church who do not support the use of parthenotes cite the 
Congregation for the Doctrine of Faith’s Donum vitae, which teaches that any attempt to 
produce, “a human being without any connection with sexuality through ‘twin fission,’ 
cloning or parthenogenesis are to be considered contrary to the moral law, since they are 
in opposition to the dignity both of human procreation and of the conjugal union” 
(Latkovic, 2002)  Their argument is that the Catholic faith is opposed to parthenogenesis 
in general because it is an attempt to unnaturally form a human being. This argument is 
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slightly confusing however, because the reasoning for using parthenotes rather than 
embryos as a source of ES cells is precisely that it would not be forming a human being.  
 
Chapter Conclusion 
 The opposition would say that medical science, if they believe heavily in its 
strengths, is here to save lives not take them.  Scientists would most likely not have to 
destroy the embryos if they can make life from it, should there be an alternative.  
Unfortunately, it seems that this provides the most promise at the moment.  The time for 
“modern medicine” has arrived.  The diseases do not seem to respond the way we would 
have hoped.  It is time to look towards futuristic medicine to get the job done.  It is time 
to consider stem cells penicillin for the 21st century. 
 To address the other option of possibly using the adult stem cells instead of the 
embryonic stem cells, all four major religions support their use so long as they are used to 
save lives.  Unfortunately these cells do not have the pleuri-potencies of ES cells, but the 
authors of this IQP strongly support their use whenever possible.   
The embryonic stem cells have been chosen for the bulk of the disease for a 
couple of reasons.  The first reason is their ability to differentiate into almost any of the 
approximate 220 types of cells.  Adult stem cells can differentiate into about six types of 
cells.  Those six types of cells are limited to neuronal activity and the blood (Weiss, 
2005), although more are being discovered all the time.  The second reason is that the 
embryonic stem cells are a lot easier to culture and isolate than adult stem cells.  Adult 
stem cells are scarcer in the body and, therefore, a lot harder to isolate. 
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 The scrutiny that scientists have had to endure over this subject alone is enough to 
drive anyone insane.  How is it possible to stand in front of someone and tell them that 
you don’t think it is ethical to destroy embryos that have been fertilized on a lab bench 
and forget about the millions of existing lives that can be saved?  How can someone call 
scientists murderers for destroying a cell mass barely visible, that has no brain or feeling, 
and protest in front of research labs?  By shutting down their research isn’t it possible that 
they are the bigger murders.  Kill a few embryos or doom millions to a slow eventual 
death.  Too many times, people have a tendency to think about the present when it should 
be time to think about the future.   
It is comforting to see that people are starting to warm up to the idea of hES cell 
research.  In a recent poll taken in Boston, MA from June 6, 2005 to June 12, 2005, sixty-
seven percent of the residents polled said they were in favor of using taxpayer money to 
fund stem cell research.  Forty percent said they were strongly in favor (Wallace, 2005).  
The poll had reached only 405 residents of the Hub, but this is at least an indication that 
the people of this country are slowly being educated on this subject.  It wouldn’t be too 
surprising to find out that those who protest this subject know very little about the details 
involved with stem cell research, especially adult stem cell research. 
It is not just Boston who has started to learn about what we are dealing with, 
however.  A Wisconsin senator tried to push for a ban in Wisconsin and at the University 
of Wisconsin-Madison on stem cell research.  Senator Scott Fitzgerald was denied on 
both accounts (Still, 2005).  There is even a recent push in the House of Representatives 
for federal funding on stem cell research.  The most recent vote, in May 2005, was 238 to 
194 in favor of federal funding for stem cell research. If this bill were to reach the 
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president’s desk in the oval office, it will most likely be vetoed, but this does prove that 
people are warming up to the idea of using stem cells to help humanity to live longer 
(Still, 2005). 
We can only hope that in the future things can be different and more ES cell lines 
can be established.  These puzzles that have been most perplexing appear to be coming 
clear.  These building blocks, these stem cells that we once were, can potentially be there 
to jump start us in the future.  When people get a big head and think they are the authority 
on everything, I can only hope that something happens to make them change their minds.   
Everything that can be done must be done now to prepare for the future. Who 
knows how many of us may develop one of these silent assassins, these killers that wish 
to bring us down from the inside.  A strong foundation and resolve is needed to fight this 
war much like the wars fought with guns and ammunition.  Scientists have nearly figured 
it out and now are just struggling to prove it, despite heavy opposition.  We have learned 
how to survive as human beings.  Now that we don’t have to fight for as much these days, 
we have lost sight of things that should be really important, such as minimizing human 
suffering.  There used to be threats just as great as these diseases and for things just as 
simple as the flu.  We, as a whole, have lost sight of many things like what it means to 
fight to survive.  No longer can we be so narrow-minded to think only of ourselves.  
Embryonic stem cell research is much like being family-oriented; and scientists have 
realized that, much like family, you can never forget your roots. 
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CHAPTER-4:  STEM CELL LEGALITIES 
 
 Years of debate concerning the use of human embryos for the advancement of 
stem cell research have yet to reconcile our strong dissenting views and translate them 
into uniform laws governing appropriate uses for fetal tissue. Yet there is a growing sense 
of a need to have uniform laws, to have a standard in place that everyone can adhere to. 
The sense of urgency is made tangible by the Human Cloning Ban and Stem Cell 
Research Protection Act of 2005 (discussed below), which attempts to allay fears and 
doubts, while still encouraging the U.S. to stay competitive and continue advancing stem 
cell research.  For the sake of saving human lives by stem cell treatments, it is vital that 
the world be able to reconcile the ethical issues and act cohesively to stay at the forefront 
of this technology.  
  
Embryonic and Fetal Research Laws within the U.S. 
 To better understand current U.S. legislative policies concerning stem cell 
research, it is important to examine the historical debate surrounding federal funding of 
human embryo research.  
• January 22, 1973: The Supreme Court decides on Roe v. Wade in favor of the 
nationwide legalization of abortion. Concerns over the use of aborted fetuses in 
scientific research prompt the Department of Health, Education and Welfare 
(DHEW) to initiate a temporary moratorium on federally funded fetal research 
(Monitoring Stem Cell Research, 1994). 
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• July 12, 1974:  Congress passes the National Research Act of 1974, due largely in 
part to rage over the Tuskegee syphilis experiments (Boonstra, 2001). In addition 
to protecting the rights of human research subjects and forming the National 
Commission for the Protection of Human Subjects of Biomedical and Behavioral 
Research, the act codifies the policy of a temporary moratorium on federally 
funded fetal research supported by DHEW (Regulations and Ethical Guidelines). 
• 1975:  The National Commission for the Protection of Human Subjects of 
Biomedical and Behavioral Research publishes their report Research on the 
Fetus: Report and Recommendations, which lifts the moratorium on fetal research 
and replaces it with regulations governing the use of federal funds for that 
research. The Commission “called for the establishment of a national Ethics 
Advisory Board within DHEW to propose standards and research protocols for 
potential federal funding of research using human embryos, and to consider 
particular applications for funding” (Regulations and Ethical Guidelines, 2005).  
• June 18, 1979:  The Ethics Advisory Board issues the “HEW Support of Human 
In Vitro Fertilization and Embryo Transfer: Report of the Ethics Advisory 
Board”, in which it deems in vitro fertilization and embryo research as acceptable, 
provided that the embryos are not beyond fourteen days of development, and that 
they are donated by married couples.  However, the board refrains from advising 
the DHEW to support funding for such projects. As a result, when the DHEW was 
left with the fiscal decision, the department at this time refused to offer funds for 
human embryonic studies (Monitoring Stem Cell Research, 1994). 
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• 1980:  The Ethics Advisory Board’s charter expires with no renewal or call for a 
replacement.  As regulations required that all proposals for funding be reviewed 
by the board, this in effect put a ban on all embryo (and thus ES cell) funding 
throughout the 1980s (Monitoring Stem Cell Research, 1994). 
• 1993:  Congress enacts the NIH Revitalization Act which negated the proposal 
review requirement for funds by the nonexistent Ethics Advisory Board. In 
theory, this new act would allow NIH funds to be appropriated for research using 
in vitro fertilized embryos (Monitoring Stem Cell Research, 1994). 
• 1994: The NIH convenes a Human Embryo Research Panel recommending that 
the creation of embryos purely for research purposes be supported under certain 
circumstances. President Clinton rejects funding the creation of embryos for 
research purposes, but permits the stipulation that research funds may be used for 
applications utilizing embryos to be discarded from in vitro fertilization 
procedures (Monitoring Stem Cell Research, 1994). 
• 1995: Congress attaches the "Dickey Amendment,” named after Rep. Jay Dickey 
of Arkansas, to the 1996 Departments of Labor, Health and Human Services, and 
Education, and Related Agencies Appropriations Act and is subsequently attached 
to the Health and Human Services appropriations bill every year thereafter. The 
provision reads as follows:  
None of the funds made available in this Act may be used for— 
(1) the creation of a human embryo or embryos for research purposes; or 
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(2) research in which a human embryo or embryos are destroyed, discarded, or 
knowingly subjected to risk of injury or death greater than that allowed for 
research on fetuses in utero under 45 CFR 46.204 and 46.207, and subsection 
498(b) of the Public Health Service Act (42 U.S.C. 289g(b)). 
(b) For purposes of this section, the term ‘human embryo or embryos’ includes 
any organism, not protected as a human subject under 45 CFR 46 as of the date of 
the enactment of the governing appropriations act, that is derived by fertilization, 
parthenogenesis, cloning, or any other means from one or more human gametes or 
human diploid cells.  
This Dickey amendment in effect forbids the use of federal funds for research in 
which human embryos are subjected to a high degree of risk, while still allowing 
private funds to be appropriated for such endeavors (Monitoring Stem Cell 
Research, 1994). 
• 1999: The General Counsel of the Department of Health and Human Services 
argues that stem cells derived from embryos that have been destroyed using 
private funding should be eligible for federal funding. The Clinton administration 
adopted this stance, and drew up guidelines for implementing this policy, but 
never got a chance to act on it since it was already near the end of Clinton’s term 
in office (Monitoring Stem Cell Research, 1994). 
 
 Over the next few years the country continued to engage in the intense debate 
over embryonic stem cell research. Religious groups and radio talk show hosts alike 
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could be heard voicing their opinions, advocating their ethical views. Republicans called 
for a ban on all funding for stem cell research on July 2, 2001. On July 23 the Pope 
condemned embryonic stem cell research (Robinson, 2005). With so many intense 
emotions surrounding this issue, people anxiously awaited the official position from the 
new Bush administration.  
 Finally on August 9, 2001 President Bush announced that he would allow limited 
funding for stem cell research. He stipulated that funding would be restricted to 
embryonic stem cell lines derived before August 9, 2001, effectively limiting the supply 
to what the NIH now believes are seventy-eight human embryonic stem cell lines (or 
preparations) (Monitoring Stem Cell Research, 1994). Although these cell lines are 
eligible for research purposes, as of August 26, 2005 research indicates that many of the 
cell lines are genetically identical, and only twenty two are actually available to 
researchers (NIH, 2005). A report by the National Institute of Health in 2003 indicated 
several international organizations possessing eligible stem cell lines for federal US 
funding (shown in Table 1).  
 
Table 1:  International Human Stem Cell Derivations Eligible for Federal US Funding 
Name Number of Derivations 
BresaGen, Inc., Athens, Georgia 4 
CyThera, Inc., San Diego, California 9 
ES Cell International, Melbourne, Australia 6 
Geron Corporation, Menlo Park, California 7 
Göteborg University, Göteborg, Sweden 19 
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Karolinska Institute, Stockholm, Sweden 6 
Maria Biotech Co. Ltd. – Maria Infertility Hospital 
Medical Institute, Seoul, Korea 
3 
MizMedi Hospital – Seoul National University, 
Seoul, Korea 
1 
National Centre for Biological Sciences/ Tata 
Institute of Fundamental Research, Bangalore, 
India  
3 
Pochon CHA University, Seoul, Korea 2 
Reliance Life Sciences, Mumbai, India 7 
Technion University, Haifa, Israel 4 
University of California, San Francisco, California 2 
Wisconsin Alumni Research Foundation, 
Madison, Wisconsin 
5 
Source: Monitoring Stem Cell Research, 1994. 
  
State Overides of the Federal Ban for Funding New ES Research 
 Although embryonic stem cell research is not currently banned in the U.S., using 
federal funds to create new ES cell lines is banned.  To compensate for this ban, the state 
of California became the first to legalize research on embryos, including cloned embryos, 
when Governor Gray Davis signed the new stem cell law SB 253 on September 23, 2002. 
The law prohibits reproductive cloning and does not directly appropriate funds for 
research.  However on November 2, 2004, California voters approved Proposition 71 
which allows the state to borrow $3 billion for stem cell research. New Jersey became the 
second state to legalize stem cell research when Governor James E. McGreevey signed a 
law on January 2, 2004, permitting research and use of human embryonic stem cells, 
germ cells, and human adult stem cells from any source (Robinson, 2005). 
 54 
 California and New Jersey are considered to be at the forefront in stem cell 
research, which is exemplified by how much they encourage this technology. Other states 
vary widely in their approach. The following table illustrates just how diverse each state 
is in its policies towards embryonic stem cells. 
 
Table 2:  State Embryonic and Fetal Research Laws 
State/Jurisdiction 
Statute Section 
Specifically 
permits 
research on 
fetus/embryo 
Restricts 
research on 
aborted fetus/ 
embryo 
Consent 
provisions to 
conduct 
research on 
fetus/embryo 
Restricts 
research on 
fetus or embryo 
resulting from 
sources other 
than abortion 
Restrictions of 
purchase/sale 
human tissue 
for research 
Arizona 
§§36-2302, 2303 
No Yes, prohibits 
research on 
aborted 
living/non-living 
embryo or fetus 
No No No 
Arkansas 
§§20-17-802, 20-
16-1001 to 1004 
No Yes, prohibits 
research on 
aborted live fetus 
Yes, consent to 
conduct research 
on aborted fetus 
born dead 
Yes, prohibits 
research on 
cloned embryos 
Yes, prohibits 
sale of 
fetus/fetal 
tissue 
California Health 
& Safety §§ 
123440, 24185, 
12115-7, 125300-
320 
Yes Yes, prohibits 
research on 
aborted live fetus 
Yes, consent to 
donate IVF 
embryo to 
research 
No Yes, prohibits 
sale for the 
purpose of 
reproductive 
cloning or for 
stem cell 
research  
Connecticut 
2005 SB 934 
Yes, on embryos 
before 
gastrulation (a 
process during 
embryonic 
development) 
 No Yes, consent to 
donate IVF 
embryo to 
research 
 No  Yes, prohibits 
payment for 
embryos, 
embryonic stem 
cells 
unfertilized 
eggs or sperm 
donated 
following IVF 
treatment  
Florida 
§390.0111 
No Yes, prohibits on 
aborted live fetus 
No No No 
Illinois 
720 ILCS 510/6, 
510/12.1 
Executive Order 6 
(2005) 
Yes, under E.O. 
6 (2005) permits 
funding of 
research that 
involves adult 
stem cells, cord 
Yes, prohibits on 
aborted living/ 
nonliving fetus 
Yes, written 
consent to 
perform research 
on cells or 
tissues from a 
dead fetus other 
Yes, prohibits 
research on 
fetus/fertilized 
embryo; 
prohibits funding 
under E.O. 6 
Yes, prohibits 
sale of 
fetus/fetal 
tissue; also 
prohibits award 
of funds for 
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blood stem cells, 
pluripotent stem 
cells, totipotent 
stem cells, 
progenitor cells, 
the product of 
somatic cell 
nuclear transfer 
or any 
combination of 
those cells 
than from an 
abortion 
(2005) of 
research on 
fetuses from 
induced 
abortions and the 
creation 
of embryos 
through the 
combination of 
gametes solely 
for the purpose 
of research 
stem cell 
research under 
E.O. 6 
(2005) to a 
person who 
purchases or 
sells embryonic 
or fetal 
cadaveric tissue 
for research 
 
State/Jurisdiction 
Statute Section 
 
Specifically 
permits 
research on 
fetus/embryo 
 
Restricts 
research on 
aborted fetus/ 
embryo 
Consent 
provisions to 
conduct 
research on 
fetus/embryo 
Restricts 
research on 
fetus or embryo 
resulting from 
sources other 
than abortion 
 
Restrictions of 
purchase/sale 
human tissue 
for research 
Indiana 
§35-46-5-1, 2005 
Senate Enrolled 
Act No. 268 
Yes, permits 
fetal stem cell 
research on 
placenta, cord 
blood, amniotic 
fluid or fetal 
tissue  
Yes, prohibits 
research on 
aborted 
living/non-living 
embryo or fetus 
Yes, consent 
required for fetal 
stem cell 
research 
Yes, prohibits 
research on 
cloned embryos 
Yes, prohibits 
sale of human 
ovum, zygote, 
embryo or fetus 
Iowa 
§§707B.1-4 
No No No Yes, prohibits 
research on 
cloned embryos 
Yes, prohibits 
transfer or 
receipt of 
oocyte, embryo 
or fetus for 
somatic cell 
nuclear transfer 
Kentucky 
§436.026 
No No No No Yes, prohibits 
sale of 
fetus/fetal 
tissue 
Louisiana 
§14: 87.2 
No No No Yes, prohibits 
research 
on fetus/embryo 
in utero, in vitro 
fertilized embryo 
No 
Maine 
22§1593 
No No No Yes, prohibits 
research on 
fetus/embryo 
born or extracted 
alive, only 
applies to in 
vitro fertilized 
embryos post-
implantation 
Yes, prohibits 
sale of 
fetus/fetal 
tissue 
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Massachusetts 
112§12J, 2005 SB 
2039 
 
 
 
Yes, on embryos 
that have not 
experienced 
more than 14 
days of 
development 
(not including 
days frozen) 
Yes, prohibits 
research on 
embryo/live 
fetus 
Yes, written 
consent to 
perform research 
on a dead fetus 
and informed 
consent to donate 
egg, sperm, or 
unused 
preimplantation 
embryos created 
for IVF 
Yes, prohibits 
research on live 
embryo or fetus; 
also prohibits 
creation on 
fertilized embryo 
solely for 
research 
Yes, prohibits 
sale of neonate, 
embryo or fetus 
for illegal 
purposes; 
prohibits sale of 
embryos, 
gametes or 
cadaveric tissue 
for research 
 
State/Jurisdiction 
Statute Section 
Specifically 
permits 
research on 
fetus/embryo 
Restricts 
research on 
aborted fetus/ 
embryo 
 
Consent 
provisions to 
conduct 
research on 
fetus/embryo 
Restricts 
research on 
fetus or embryo 
resulting from 
sources other 
than abortion 
 
Restrictions of 
purchase/sale 
human tissue 
for research 
Michigan 
§§333.2687-2688, 
§§333.16274-
16275, 333.20197, 
333.26401-26403, 
750.430a 
No Yes, live 
embryo/ 
fetus 
Yes, written 
consent of 
mother to donate 
dead embryo, 
fetus or neonate 
to research 
Yes, prohibits 
research on a 
live 
embryo or fetus, 
cloned embryo 
No 
Minnesota 
§§145.421, 422 
No No No Yes, prohibits 
research on a 
live embryo up 
to 265 post 
fertilization or 
fetus 
Yes, permits 
the 
sale/purchase of 
cell culture 
lines from 
nonliving 
human 
conceptus 
Missouri 
§§188.036, 037 
No Yes, prohibits 
research on a 
fetus alive pre-
abortion 
No No Yes, prohibits 
receipt of 
valuable 
consideration 
for aborted fetal 
organs or tissue 
Montana 
§50-20-108(3) 
No Yes, prohibits 
research on a 
live fetus 
No No No 
Nebraska 
§§28-342, 346, 
71-7606 
No Prohibits 
research on 
aborted live fetus 
or the use of 
state funds for 
research on fetal 
tissue obtained 
from an abortion 
No Yes, limits the 
use of state funds 
for embryonic 
stem cell 
research; 
restrictions only 
apply to state 
healthcare cash 
funds provided 
by tobacco 
settlement 
dollars 
Yes, prohibits 
sale, 
distribution or 
donation of 
viable aborted 
child 
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New Hampshire 
§§168-B-1, 15  
No No No Yes, prohibits 
the maintenance 
of a unfrozen 
fertilized pre-
embryo past 14 
days 
Yes 
New Jersey 
2002-2003 
SB1909/AB2840 
Yes No Yes No No 
 
State/Jurisdiction 
Statute Section 
 
Specifically 
permits 
research on 
fetus/embryo 
 
Restricts 
research on 
aborted fetus/ 
embryo 
 
Consent 
provisions to 
conduct 
research on 
fetus/embryo 
 
Restricts 
research on 
fetus or embryo 
resulting from 
sources other 
than abortion 
 
Restrictions of 
purchase/sale 
human tissue 
for research 
New Mexico 
§24-9A-1, 3, 5 
No No No Yes, prohibits 
research on a 
fetus/embryo 
born or extracted 
alive, only 
applies to in 
vitro fertilized 
embryos post-
implantation 
Yes, prohibits 
abortion for the 
purpose of 
selling the fetus 
to researchers 
North Dakota 
§14-02.2-01, 2; 
HB 1424 
No Yes, prohibits 
research on a 
living/non-living 
embryo or fetus 
Yes, requires 
consent to 
conduct research 
on a nonliving 
fetus or embryo 
other than from 
an abortion 
Yes, prohibits 
research on a 
fetus born or 
extracted alive; 
cloned embryos 
Yes, prohibits 
the sale of a 
fetus to be used 
for illegal 
purposes 
Ohio 
§2919.14 
No Yes, prohibits 
research on a 
living/non-living 
embryo or fetus 
No No Yes, prohibits 
sale of fetus or 
fetal remains 
from an 
abortion 
Oklahoma 
63 §1-735 
No Yes, prohibits 
research on a 
fetus/embryo 
No No Yes, prohibits 
sale of fetus or 
fetal remains 
Pennsylvania 
18 §§3203, 3216 
No Yes, prohibits 
research on a 
live embryo or 
fetus 
Consideration 
may not be given 
to mothers 
consenting to 
research; in cases 
involving 
abortion, consent 
must be provided 
after decision to 
abort 
No Yes, 
consideration 
may not be 
given to 
mothers 
consenting to 
research or 
other 
transferring 
tissue except 
for expenses 
involved in 
actual retrieval, 
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storage, etc. 
 
 
 
 
     
State/Jurisdiction 
Statute Section 
Specifically 
permits 
research on 
fetus/embryo 
Restricts 
research on 
aborted fetus/ 
embryo 
Consent 
provisions to 
conduct 
research on 
fetus/embryo 
Restricts 
research on 
fetus or embryo 
resulting from 
sources other 
than abortion 
Restrictions of 
purchase/sale 
human tissue 
for research 
Rhode Island 
§11-54-1 
No No Yes Yes, prohibits 
research on a 
fetus/embryo 
born or extracted 
alive, only 
applies to in 
vitro fertilized 
embryos post-
implantation 
Yes, prohibits 
sale of neonate, 
embryo or fetus 
for illegal 
purposes 
South Dakota 
§§34-14-16, 17, 
20; 34-23A-17 
No Yes, prohibits 
research on a 
living/non-living 
embryo or fetus15 
No Yes, prohibits 
research on 
embryo outside 
of a woman's 
body; research 
on cells or 
tissues derived 
from an embryo 
outside a 
woman's body 
Yes, prohibits 
sale of embryo 
Tennessee 
§39-15-208 
No No Yes, consent 
required to 
conduct research 
on aborted fetus 
No Yes, prohibits 
sale of aborted 
fetus 
Texas Penal 
Code §48.02 
No No No No Prohibits sale of 
fetus/fetal 
tissue 
Utah 
§§76-7-301, 310 
No Noi No Yes, prohibits 
research on a 
live fetus, 
fertilized embryo 
post-
implantation1 
Yes, prohibits 
sale of 
fetus/fetal 
tissue; also 
prohibits sale of 
live unborn 
children, which 
is not defined, 
but are referred 
to in abortion 
statute1 
Virginia 
§32.1-162.32-2 
No No No May prohibit 
research on a 
Yes, prohibits 
shipping or 
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cloned embryo 
or fetus2 
receiving of the 
product of 
human cloning 
for commerce2 
 
 
 
     
State/Jurisdiction 
Statute Section 
Specifically 
permits 
research on 
fetus/embryo 
Restricts 
research on 
aborted fetus/ 
embryo 
Consent 
provisions to 
conduct 
research on 
fetus/embryo 
Restricts 
research on 
fetus or embryo 
resulting from 
sources other 
than abortion 
Restrictions of 
purchase/sale 
human tissue 
for research 
Wyoming 
§35-6-115 
No No No No Yes, prohibits 
sale, 
distribution or 
donation of live 
or viable 
aborted child, 
defined to 
include 
embryos, for 
experimentation 
Source: Johnson, 2005 
 
 It should be noted that on May 31, 2005 an “Act Enhancing Regenerative 
Medicine in the Commonwealth”, including a chapter on biotechnology, passed both the 
Senate and the House of Representatives in the state of Massachusetts. This law says in 
part, that "it shall be the policy of the Commonwealth to actively foster research and 
therapies in the life sciences and regenerative medicine by permitting research and 
clinical applications involving the derivation and use of human embryonic stem cells, 
including research and clinical applications involving somatic cell nuclear transfer, 
placental and umbilical cord blood cells and human adult stem cells, and other 
mechanisms to create embryonic stem cells which are consistent with this act. It shall 
further be the policy of the commonwealth to prohibit human reproductive cloning" 
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(Chapter 27 of the Acts of 2005, 2005). As one of the three largest biotechnology sectors 
in the U.S., Massachusetts continues to be among the leaders of medical innovation.  
 
World Embryonic Stem Cell Policies 
 Now we turn our attention to ES cell policies in some other representative 
countries.  Figure-1 below denotes the relative permissiveness of various countries for ES 
cell research.  The brown color denotes permissive policies (i.e. Japan, South Korea, 
China, India, Sweden, Finland, and England.  The orange color denotes flexible policies 
(but not totally permissive) (i.e. Brazil, Canada, Spain, Russia, Australia).  The yellow 
color denotes restrictive policies (i.e. U.S., Africa, Italy, Saudi Arabia, Malaysia).  
Representing 3.4 billion people, the map shows that over half the world’s populations are 
either “flexible” or “permissive” in their policies on embryonic stem cell research. 
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Fig. 1: World Stem Cell Map (Hoffman, 2005). 
Map Explanation  
• "permissive" = various embryonic stem cell derivation techniques including 
somatic cell nuclear transfer (SCNT), also called research or therapeutic cloning. 
SCNT is the transfer of a cell nucleus from a somatic or body cell into an egg 
from which the nucleus has been removed. Countries in this category include the 
United Kingdom, Belgium, Sweden, Israel, India, Singapore, China, Japan, South 
Korea, South Africa, and others. [Walters, LeRoy, National Academy of Sciences, 
Oct. 12, 2004.] These countries represent a global population of approximately 
2.7 billion people. 
• "flexible" = derivations from fertility clinic donations only, excluding SCNT, 
and often under certain restrictions. Countries in this category include Australia, 
Brazil, Canada, France, Spain, The Netherlands, Taiwan and others. [Walters, 
LeRoy, National Academy of Sciences, Oct. 12, 2004.] These countries represent 
a global population of approximately 700 million people.  
• ”restrictive” = countries with restricted stem cell policies ranging from heavy 
stipulations to an outright ban on stem cell research. Countries include the U.S., 
many African countries, Italy, Saudi Arabia, and Malaysia.  
• Map is designed to reflect national policy and whether or not public funds may 
be used to pursue stem cell research using IVF embryos donated from fertility 
clinics. (Hoffman) 
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 The moratorium on the dispersing of funds for stem cell research in the European 
Union ended on December 31, 2003.  Despite opposing views by member nations, the 
EU has taken the position of funding research on a case by case basis (“EU to Fund Stem 
Cell Research Despite Split,” 2003). Just last year on August 11, 2004, the United 
Kingdom issued a license to the Newcastle Center for life allowing them to create 
colonies of human stem cells for research (Garfinkle, 2004). It is strikingly clear that 
much of the world is gaining a foothold in stem cell research, and that legal measures 
should be taken to ensure U.S. competitiveness, while still balancing out the ethical 
concerns. Drafting a policy to allow the use of embryos taken from IVF clinics with 
parental consent, with no monetary inducement for the donors, and with embryos 
cultured for less than 14 days (which would include the blastocyst from which ES cells 
are obtained) seems to be a logical compromise supported by the authors of this IQP. 
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CONCLUSIONS 
 
 
 Stem cell research is possibly the most misunderstood and misrepresented area of 
science today.  When the media makes reference to “stem cells”, they are usually 
referring to ES cells, a generalization that has lead to controversy and misinformation.  
There are many types of stem cells, including those termed “adult stem cells”, which can 
be found in a grown human being.  While these adult stem cells have less potential ability 
than ES cells, they may still provide cures from ruthless killers such as degenerative 
diseases.  For example, adult neuronal stem cells may be able to regenerate fresh brain 
cells in a Parkinson’s patient. 
 ES cells are blank cells that can differentiate into almost any type of cell in a 
human body.  They are capable of replicating much longer than any normal cell.  Normal 
cells, after some time, are dictated by their biological makeup to stop replicating. Stem 
cells are not told to stop.  This resume makes any sort of stem cell a viable candidate for 
becoming the foremost maintenance tool for the body.  The world has seen much 
evidence to back up these claims, from using adult hematopoietic stem cells to send 
leukemia into full remission, to using ES cells to reverse diabetes in mice.   
 There have been many advances, but still U.S. stem cell research operates under 
overly strict regulations.  It would be wise to allow this stem research to develop.  Many 
oppose the use of embryos (from which ES cells are obtained) since they argue the 
embryos are “living entities”.  However, three of the four major world’s religions support 
the use of ES cells since the blastocysts from which they are taken is no bigger than the 
period at the end of this sentence, and they argue life begins much later in the pregnancy.  
Some Catholics argue destroying blastocysts represent “murderous acts”, however even 
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Catholics are in favor of using adult stem cells, so long as they are used to support the 
common good.  It is even possible that those who oppose ES cell research will be in need 
of stem cell assistance one day, and recognize that using one blastocyst with no feeling, 
no brain, no ensoulement, might be used to save hundreds of lives. 
 This world was made the way it is today through hard work and sacrifice.  Too 
many times we forget the past, and how many before us have given up their lives so that 
our way of life can be preserved.  Everything has its cost, and it is only fitting that there 
be a sacrifice to preserve humanity. 
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